Oral topotecan plus BSC- gruppen oplevede en statistisk signifikant forbedring i samlet overlevelse sam - menlignet med gruppen med BSC alene (log- rank p = 0, 0104).
Oral topotecan plus BSC group had a statistically significant improvement in overall survival compared with the BSC alone group (Log-rank p=0.0104).